# Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

> **NCT00593944** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 15 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** MDX-1342

## Key facts

- **NCT ID:** NCT00593944
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00593944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00593944, "Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00593944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*